Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock - Chima, R S; Hake, P W; Piraino, G; Mangeshkar, P; Denenberg, A; Zingarelli, B (Crit Care Med, 2008)